Changes in Gut Microbiota by Chronic Stress Impair the Efficacy of Fluoxetine
Summary: Major depressive disorders (MDDs) constitute a leading cause of disability worldwide and current pharmacological treatments are partially effective. The gut microbiota (GM) has recently emerged as a target of therapeutic interest for MDDs. In this study, we transfer GM from mice that sustai...
Main Authors: | Eleni Siopi, Grégoire Chevalier, Lida Katsimpardi, Soham Saha, Mathilde Bigot, Carine Moigneu, Gérard Eberl, Pierre-Marie Lledo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124720302734 |
Similar Items
-
Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system
by: Grégoire Chevalier, et al.
Published: (2020-12-01) -
Antidepressants fluoxetine and amitriptyline induce alterations in intestinal microbiota and gut microbiome function in rats exposed to chronic unpredictable mild stress
by: Weijie Zhang, et al.
Published: (2021-02-01) -
Gut microbiota impairs insulin clearance in obese mice
by: Kevin P. Foley, et al.
Published: (2020-12-01) -
Metagenomic Surveys of Gut Microbiota
by: Rahul Shubhra Mandal, et al.
Published: (2015-06-01) -
The crosstalk between the gut microbiota and lipids☆
by: Gérard Philippe
Published: (2020-01-01)